Skip to main content
. 2023 Feb 23;64(3):459–477. doi: 10.1007/s13353-023-00750-2

Table 2.

Completed clinical studies on miRNAs (based on ClinicalTrials.gov (accessed on 30 November 2022))

No NCT no Study title Cancer Location Participants
(Active/original)
NCT03452514

Addition of microRNA Blood Test to Lung Cancer Screening Low

Dose CT

Lung cancer

Massachusetts General Hospital, Boston, Massachusetts, USA

Brigham and Women’s Hospital, Boston, Massachusetts, USA

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA

Lahey Hospital & Medical Center, Burlington, Massachusetts, USA

479/479
NCT02445924 MicroRNA Genetic Signature in NSCLC Egyptian Patients Non-small cell lung cancer Chest Department, Faculty of Medicine, Tanta University, Tanta, Gharbia, Egypt 40/40
NCT03293433 Quantification of microRNAs in Diagnosis of Pulmonary Nodule Pulmonary cancer

University Hospital of la Réunion, France

University Hospital of Toulouse, Toulouse, France

103/103
4 NCT03741829 TS Overexpression in SCLC: Mechanism and Therapeutic Targeting Small cell lung cancer Wake Forest University Health Sciences Wilson-Salem, North Carolina, USA 12/12
5 NCT00897234 Blood Samples From Patients From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers Lung cancer

Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota

USA

84/84
6 NCT00864266 Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer Non-small cell lung cancer

Department of Pneumology Clinique Saint-Luc, Bouge, Belgium

Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, Belgium

Service de Pneumologie Hôpital Erasme, Brussels, Belgium

Department of Pneumology Hôpital Saint-Joseph, Gilly, Belgium

Hôpital Ambroise Paré, Mons, Belgium

Department of Pneumology Centre Hospitalier de Mouscron, Mouscron, Belgium

70/70
7 NCT02837809 Early Lung Cancer Detection in High Risk Individuals Lung cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy 4099/4099
8 NCT00840125 Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment Non-small cell lung cancer Meir Medical Center, Kfar Saba, Israel 4/40
9 NCT02369198 MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLC

Malignant pleural mesothelioma

Non-small cell lung cancer

Concord Repatriation General Hospital, Sydney, New South Wales, Australia

Chris O'Brien Lifehouse, Sydney, New South Wales, Australia

Northern Cancer Institute, Sydney, New South Wales, Australia

27/30
10 NCT00926640 A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers

Carcinoma neuroendocrine

Small cell lung cancer carcinoma

Malignant epithelial neoplasms

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, USA 28/44
11 NCT01779388 Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules Pulmonary nodule Cm Institut Jules Bordet, Brussels, Belgium 120/120
12 NCT02387307 A Study of rSIFN-co in Subjects With Advanced Solid Tumors

Carcinoma, non-small-cell lung

Carcinoma,

Renal cell

Melanoma

Carcinoma, hepatocellular

Colon cancer

National Cancer Centre Singapore, Singapore 42/42
13 NCT02169271 Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Multiple pulmonary nodules

M D Anderson Cancer Center, Houston, Texas, USA

European Institute of Oncology, Milano, Italy

109/128
14 NCT02194231 ATREUS—Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM) Malignant pleural mesothelioma

Azienda ospedaliera ss. Antonio e Biagio e Cesare Arrigo, Alessandria, AL, Italy

Cliniche Humanitas Gavazzeni, Bergamo, BG, Italy

Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Bo, Italy

P.O. Spedalli Civili, Brescia, BS, Italy

Azienda Ospedaliera S. Gerardo di Monza, Monza, MB, Italy

Istituto Clinico Humanitas, Rozzano, MI, Italy •Istituto Oncologico Veneto—IOV, Padova, PD, Italy •Azienda Ospedaliro-Universitaria di Parma, Parma, Italy

145/145